OpenURL Connection Search

Select item for more details and to access through your institution.

Romiplostim for management of chemotherapy-induced thrombocytopenia.
Published in:
Supportive Care in Cancer, 2014, v. 22, n. 5, p. 1217, doi. 10.1007/s00520-013-2074-2
By:
- Parameswaran, R.;
- Lunning, M.;
- Mantha, S.;
- Devlin, S.;
- Hamilton, A.;
- Schwartz, G.;
- Soff, G.
Publication type:
Article
Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis.
Published in:
Leukemia (08876924), 2015, v. 29, n. 1, p. 237, doi. 10.1038/leu.2014.261
By:
- Schatz, J H;
- Horwitz, S M;
- Teruya-Feldstein, J;
- Lunning, M A;
- Viale, A;
- Huberman, K;
- Socci, N D;
- Lailler, N;
- Heguy, A;
- Dolgalev, I;
- Migliacci, J C;
- Pirun, M;
- Palomba, M L;
- Weinstock, D M;
- Wendel, H-G
Publication type:
Article
LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN R/R MCL: PRIMARY ANALYSIS RESULTS FROM THE MCL COHORT OF THE SINGLE‐ARM, MULTICENTER, SEAMLESS DESIGN TRANSCEND NHL 001 STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 875, doi. 10.1002/hon.3196_LBA3
By:
- Wang, M.;
- Siddiqi, T.;
- Gordon, L. I.;
- Kamdar, M.;
- Lunning, M.;
- Hirayama, A. V.;
- Abramson, J. S.;
- Arnason, J.;
- Ghosh, N.;
- Mehta, A.;
- Andreadis, C.;
- Solomon, S. R.;
- Kostic, A.;
- Dehner, C.;
- Espinola, R.;
- Peng, L.;
- Ogasawara, K.;
- Chattin, A.;
- Palomba, M. L.
Publication type:
Article
BISPECIFIC ANTI‐CD20/19 CAR‐T—ZAMTOCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY DLBCL—INTERIM ANALYSIS RESULTS OF DALY‐II‐USA STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 147, doi. 10.1002/hon.3163_96
By:
- Ulrickson, M.;
- Miklos, D. B.;
- Maziarz, R. T;
- Jacobson, C.;
- Isufi, I.;
- Ghosh, M.;
- Perales, M.;
- Lunning, M.;
- Hardy, N. M.;
- Wijatyk, A.;
- Ancukiewicz, M.;
- Nallewar, M.;
- Coleman, K. C.;
- Prudner, B. C;
- Eromosele, E.;
- Kaleta, R.;
- Shah, N. N.
Publication type:
Article
AN OPEN‐LABEL TRIAL OF ORAL CA‐4948 AN IRAK4 INHIBITOR COMBINED WITH IBRUTINIB IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.169_2880
By:
- Joffe, E.;
- Ramchandren, R.;
- Nowakowski, G.;
- Rosenthal, A.;
- Tun, H. W.;
- Lunning, M.;
- Mead, M. D.;
- Martinez, E.;
- von Roemeling, R.;
- Leslie, L.
Publication type:
Article
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL LYMPHOMA: PHASE II RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 280, doi. 10.1002/hon.91_2630
By:
- Lunning, M.;
- Horwitz, S.;
- Advani, R.;
- Vose, J.;
- Lee, H.;
- Mehta‐Shah, N.;
- Zain, J.;
- Haverkos, B.;
- Lechowicz, M.;
- Moskowitz, A.;
- Heires, P.;
- Lyden, L.;
- Ansell, S.
Publication type:
Article
A PHASE IIA STUDY EVALUATING THE SAFETY AND TOLERABILITY OF UMBRALISIB AND IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 519, doi. 10.1002/hon.204_2631
By:
- Lunning, M.;
- Bierman, P.;
- Bociek, R.;
- Armitage, J.;
- Heires, P.;
- Blumel, S.;
- Hohenstein, M.;
- Lyden, L.;
- Vose, J.
Publication type:
Article
TREATMENT AND OUTCOMES OF PATIENTS WITH NK/T‐CELL LYMPHOMA TREATED WITH MODIFIED (m)SMILE AND INTENSITY‐MODULATED RADIOTHERAPY (IMRT), A SINGLE CENTER EXPERIENCE.
Published in:
Hematological Oncology, 2019, v. 37, p. 477, doi. 10.1002/hon.156_2631
By:
- Ghione, P.;
- Qi, S.;
- Imber, B.S.;
- Venkatraman, S.;
- Moskowitz, A.;
- Galasso, N.;
- Lunning, M.;
- Straus, D.;
- Sauter, C.;
- Dahi, P.;
- Dogan, A.;
- Yahalom, J.;
- Horwitz, S.M.
Publication type:
Article
SAFETY OF LISOCABTAGENE MARALEUCEL GIVEN WITH DURVALUMAB IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B‐CELL NON HODGKIN LYMPHOMA: FIRST RESULTS FROM THE PLATFORM STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 171, doi. 10.1002/hon.128_2629
By:
- Siddiqi, T.;
- Abramson, J.S.;
- Lee, H.J.;
- Schuster, S.;
- Hasskarl, J.;
- Montheard, S.;
- Dell Aringa, J.;
- Thompson, E.;
- Ananthakrishnan, R.;
- Lunning, M.
Publication type:
Article
SAFETY AND PRELIMINARY EFFICACY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL IN TRANSCEND NHL 001.
Published in:
Hematological Oncology, 2019, v. 37, p. 301, doi. 10.1002/hon.111_2630
By:
- Wang, M.;
- Gordon, L.I.;
- Palomba, M.L.;
- Abramson, J.S.;
- Andreadis, C.;
- Ghosh, N.;
- Lunning, M.;
- Maloney, D.;
- Farazi, T.;
- Garcia, J.;
- Xie, B.;
- Newhall, K.;
- Dehner, C.;
- Siddiqi, T.
Publication type:
Article
SAFETY AND EFFICACY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN OLDER PATIENTS: RESULTS FROM THE US LYMPHOMA CAR‐T CONSORTIUM.
Published in:
Hematological Oncology, 2019, v. 37, p. 304, doi. 10.1002/hon.113_2630
By:
- Sano, D.;
- Lekakis, L.;
- Feng, L.;
- Nastoupil, L.J.;
- Jain, M.D.;
- Spiegel, J.Y.;
- Dahiya, S.;
- Lin, Y.;
- Ghobadi, A.;
- Lunning, M.;
- Hill, B.T.;
- Reagan, P.;
- Oluwole, O.;
- McGuirk, J.;
- Sehgal, A.;
- Deol, A.;
- Charalambos, A.;
- Goy, A.H.;
- Munoz, J.;
- Cashen, A.
Publication type:
Article
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL LYMPHOMA: PHASE II RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 280, doi. 10.1002/hon.91_2630
By:
- Lunning, M.;
- Horwitz, S.;
- Advani, R.;
- Vose, J.;
- Lee, H.;
- Mehta‐Shah, N.;
- Zain, J.;
- Haverkos, B.;
- Lechowicz, M.;
- Moskowitz, A.;
- Heires, P.;
- Lyden, L.;
- Ansell, S.
Publication type:
Article
A PHASE IIA STUDY EVALUATING THE SAFETY AND TOLERABILITY OF UMBRALISIB AND IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 519, doi. 10.1002/hon.204_2631
By:
- Lunning, M.;
- Bierman, P.;
- Bociek, R.;
- Armitage, J.;
- Heires, P.;
- Blumel, S.;
- Hohenstein, M.;
- Lyden, L.;
- Vose, J.
Publication type:
Article
TREATMENT AND OUTCOMES OF PATIENTS WITH NK/T‐CELL LYMPHOMA TREATED WITH MODIFIED (m)SMILE AND INTENSITY‐MODULATED RADIOTHERAPY (IMRT), A SINGLE CENTER EXPERIENCE.
Published in:
Hematological Oncology, 2019, v. 37, p. 477, doi. 10.1002/hon.156_2631
By:
- Ghione, P.;
- Qi, S.;
- Imber, B.S.;
- Venkatraman, S.;
- Moskowitz, A.;
- Galasso, N.;
- Lunning, M.;
- Straus, D.;
- Sauter, C.;
- Dahi, P.;
- Dogan, A.;
- Yahalom, J.;
- Horwitz, S.M.
Publication type:
Article
SAFETY OF LISOCABTAGENE MARALEUCEL GIVEN WITH DURVALUMAB IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B‐CELL NON HODGKIN LYMPHOMA: FIRST RESULTS FROM THE PLATFORM STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 171, doi. 10.1002/hon.128_2629
By:
- Siddiqi, T.;
- Abramson, J.S.;
- Lee, H.J.;
- Schuster, S.;
- Hasskarl, J.;
- Montheard, S.;
- Dell Aringa, J.;
- Thompson, E.;
- Ananthakrishnan, R.;
- Lunning, M.
Publication type:
Article
SAFETY AND EFFICACY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN OLDER PATIENTS: RESULTS FROM THE US LYMPHOMA CAR‐T CONSORTIUM.
Published in:
Hematological Oncology, 2019, v. 37, p. 304, doi. 10.1002/hon.113_2630
By:
- Sano, D.;
- Lekakis, L.;
- Feng, L.;
- Nastoupil, L.J.;
- Jain, M.D.;
- Spiegel, J.Y.;
- Dahiya, S.;
- Lin, Y.;
- Ghobadi, A.;
- Lunning, M.;
- Hill, B.T.;
- Reagan, P.;
- Oluwole, O.;
- McGuirk, J.;
- Sehgal, A.;
- Deol, A.;
- Charalambos, A.;
- Goy, A.H.;
- Munoz, J.;
- Cashen, A.
Publication type:
Article
SAFETY AND PRELIMINARY EFFICACY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL IN TRANSCEND NHL 001.
Published in:
Hematological Oncology, 2019, v. 37, p. 301, doi. 10.1002/hon.111_2630
By:
- Wang, M.;
- Gordon, L.I.;
- Palomba, M.L.;
- Abramson, J.S.;
- Andreadis, C.;
- Ghosh, N.;
- Lunning, M.;
- Maloney, D.;
- Farazi, T.;
- Garcia, J.;
- Xie, B.;
- Newhall, K.;
- Dehner, C.;
- Siddiqi, T.
Publication type:
Article
HIGH CR RATES IN RELAPSED/REFRACTORY (R/R) AGGRESSIVE B-NHL TREATED WITH THE CD19-DIRECTED CAR T CELL PRODUCT JCAR017 (TRANSCEND NHL 001).
Published in:
Hematological Oncology, 2017, v. 35, p. 138, doi. 10.1002/hon.2437_127
By:
- Abramson, J.;
- Palomba, M.L.;
- Gordon, L.;
- Lunning, M.;
- Arnason, J.;
- Wang, M.;
- Forero ‐ Torres, A.;
- Albertson, T.;
- Allen, T.;
- Sutherland, C.;
- Xie, B.;
- Garcia, J.;
- Siddiqi, T.
Publication type:
Article
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II-IV PERIPHERAL T-CELL NON-HODGKIN LYMPHOMA: PHASE I RESULTS FROM THE T-CELL CONSORTIUM.
Published in:
Hematological Oncology, 2017, v. 35, p. 411, doi. 10.1002/hon.2439_190
By:
- Lunning, M.;
- Horwitz, S.;
- Mehta ‐ Shah, N.;
- Moskowitz, A.;
- Advani, R.;
- Beaven, A.;
- Haverkos, B.;
- Lechowicz, M.;
- Oki, Y.;
- Zain, J.;
- Ansell, S.
Publication type:
Article

Found: 19